Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Melanoma, Cutaneous Malignant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 0 results

Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Testing effectiveness (Phase 2)Study completedNCT01693068
What this trial is testing

Phase II Trial of Pimasertib Versus Dacarbazine in N-Ras Mutated Cutaneous Melanoma

Who this might be right for
N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma
EMD Serono 194
Not applicableNot Yet RecruitingNCT07005297
What this trial is testing

Clinical Genetics Branch Eligibility Screening Survey

Who this might be right for
MelanomaLi-Fraumeni SyndromePulmonary Blastoma+7 more
National Cancer Institute (NCI) 1,000
Early research (Phase 1)Active Not RecruitingNCT04620603
What this trial is testing

Low-Dose-Rate Brachytherapy Combined With Immune Checkpoint Inhibition in Cancer

Who this might be right for
Cutaneous Malignant MelanomaRenal Cell CancerUrothelial Cancer of Renal Pelvis
Case Comprehensive Cancer Center 5
Testing effectiveness (Phase 2)Ended earlyNCT00601861
What this trial is testing

Effect of rIL-21 on Metastases in Lymph Nodes in Melanoma Skin Cancer

Who this might be right for
CancerMalignant Melanoma
Novo Nordisk A/S 1
Early research (Phase 1)Ended earlyNCT05341349
What this trial is testing

Stereotactic Radiosurgery and Immune Checkpoint Inhibitors With NovoTTF-200M for the Treatment of Melanoma Brain Metastases

Who this might be right for
Clinical Stage IV Cutaneous Melanoma AJCC v8Melanoma of Unknown PrimaryMetastatic Malignant Neoplasm in the Brain+4 more
Emory University 1
Testing effectiveness (Phase 2)Ended earlyNCT04168528
What this trial is testing

Phase I/IIa Study of 68GaNOTA-Anti-MMR-VHH2 for PET/CT

Who this might be right for
Malignant Solid TumorBreast CancerMelanoma (Skin)
Universitair Ziekenhuis Brussel 13
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Large-scale testing (Phase 3)Looking for participantsNCT07440290
What this trial is testing

DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers.

Who this might be right for
Haematological MalignancyMalignant NeoplasmLymphoproliferative Disorders+17 more
Cancer Research UK 30
Testing effectiveness (Phase 2)Study completedNCT00976573
What this trial is testing

Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma

Who this might be right for
Melanoma (Skin)
Alliance for Clinical Trials in Oncology 149
Early research (Phase 1)Study completedNCT05479812
What this trial is testing

Dose Escalation and Expansion Study of WTX-124 as Monotherapy and in Combination With Pembrolizumab (Pembro) in Patients With Selected Advanced or Metastatic Solid Tumors

Who this might be right for
Metastatic Solid TumorAdvanced Solid Tumor
Werewolf Therapeutics, Inc. 156
Early research (Phase 1)Study completedNCT00004244
What this trial is testing

Interleukin-12 and Interferon Alfa in Treating Patients With Metastatic Kidney Cancer or Malignant Melanoma

Who this might be right for
Kidney CancerMelanoma (Skin)
National Cancer Institute (NCI) 30